GLS1 inhibitors for treating disease
Disclosed herein are compounds of structural Formula VIIa or VIIb: or a pharmaceutically acceptable salt thereof, and compositions thereof useful in the treatment of GLS1 mediated diseases, such as cancer. Methods of inhibition GLS1 activity in a human or animal subject are also provided. 
Board of Regents, The University of Texas System
A A A A C A A C A C A C C A C A C A
A61K A61K A61K A61P C07D A61K A61K C07D A61P C07D A61P C07D C07D A61K C07D A61K C07D A61K
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Wylie S. Gang Matthew M. Zhijun Timothy Kang Anne Jay Philip Barbara Timothy Michael J. Richard Zachary Maria Emilia Jason P. Christopher Lawrence
Palmer Liu Hamilton Kang McAfoos Le Yau Theroff Jones Czako Heffernan Soth Lewis Herrera Di Francesco Burke Carroll